dapi has been researched along with Cochlear Hearing Loss in 2 studies
DAPI: RN given refers to parent cpd.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment of sensorineural hearing loss could be advanced using novel drug carriers such as hyperbranched polylysine (HBPL) or lipid nanocapsules (LNCs)." | 1.35 | Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules. ( Kadlecova, Z; Klok, HA; Lenarz, T; Perrier, T; Saulnier, P; Scheper, V; Scholl, M; Stöver, T; Wolf, M, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mahrt, EJ | 1 |
Perkel, DJ | 1 |
Tong, L | 1 |
Rubel, EW | 1 |
Portfors, CV | 1 |
Scheper, V | 1 |
Wolf, M | 1 |
Scholl, M | 1 |
Kadlecova, Z | 1 |
Perrier, T | 1 |
Klok, HA | 1 |
Saulnier, P | 1 |
Lenarz, T | 1 |
Stöver, T | 1 |
2 other studies available for dapi and Cochlear Hearing Loss
Article | Year |
---|---|
Engineered deafness reveals that mouse courtship vocalizations do not require auditory experience.
Topics: Acoustic Stimulation; Acoustics; Animals; Animals, Newborn; Deafness; Diphtheria Toxin; Evoked Poten | 2013 |
Potential novel drug carriers for inner ear treatment: hyperbranched polylysine and lipid nanocapsules.
Topics: Animals; Cochlea; Drug Carriers; Ear, Inner; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Guinea | 2009 |